Xylem reported revenue of $9.04 billion for fiscal year 2025 (ended December 31, 2025), up 5.5% from fiscal year 2024. Net income was $957.00 million, a net margin of 10.6%.
At the end of fiscal year 2025 it had total assets of $17.63 billion, total liabilities of $6.15 billion and shareholders' equity of $11.48 billion, with total debt of $2.07 billion.
Its operations brought in $1.24 billion of cash.
The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.
Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

Annual • USD
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | $9.0B | $8.6B | $7.4B | $5.5B | $5.2B |
| Gross profit | $3.5B | $3.2B | $2.7B | $2.1B | $2.0B |
| Operating income | $1.2B | $963.0M | $651.0M | $483.0M | $592.0M |
| Net income | $957.0M | $890.0M | $609.0M | $355.0M | $427.0M |
| Diluted EPS | – | – | – | – | $2.35 |
| Total assets | $17.6B | $16.5B | $16.1B | $8.0B | $8.3B |
| Total liabilities | $6.2B | $5.9B | $5.9B | $4.5B | $5.1B |
| Shareholders' equity | $11.5B | $10.6B | $10.2B | $3.5B | $3.2B |
| Cash | – | – | – | – | $1.3B |
| Total debt | $2.1B | $2.1B | $2.4B | $1.9B | $2.5B |
| Operating cash flow | $1.2B | $1.3B | $837.0M | $596.0M | $538.0M |
| Capital spending | – | – | – | – | $208.0M |
| Free cash flow | – | – | – | – | $330.0M |
In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2020.
$9.04 billion, up 5.5% from $8.56 billion in fiscal year 2024.
Xylem reported net income of $957.00 million for fiscal year 2025 (10.6% of revenue); operating income was $1.19 billion.
At the end of fiscal year 2025: total debt of $2.07 billion.